EPISODE · Dec 16, 2023 · 36 MIN
David Baram: Founder and CEO of EmendoBio
from BioBoss · host David Baram
David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.
Embed this episode
Ready to play
David Baram: Founder and CEO of EmendoBio
0:00
36:03
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of BioBoss?
This episode is 36 minutes long.
When was this BioBoss episode published?
This episode was published on December 16, 2023.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this BioBoss episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!